Exact Mass: 347.12228820000007
Exact Mass Matches: 347.12228820000007
Found 472 metabolites which its exact mass value is equals to given mass value 347.12228820000007,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Hydroxysanguinarine
C20H13NO5 (347.07936880000005)
Hydroxysanguinarine is a benzophenanthridine alkaloid. Hydroxysanguinarine is a natural product found in Fumaria indica, Fumaria parviflora, and other organisms with data available.
Cephalexin
C16H17N3O4S (347.09397220000005)
Cephalexin is only found in individuals that have used or taken this drug. It is a semisynthetic cephalosporin antibiotic with antimicrobial activity similar to that of cephaloridine or cephalothin, but somewhat less potent. It is effective against both gram-positive and gram-negative organisms. [PubChem]Cephalexin, like the penicillins, is a beta-lactam antibiotic. By binding to specific penicillin-binding proteins (PBPs) located inside the bacterial cell wall, it inhibits the third and last stage of bacterial cell wall synthesis. Cell lysis is then mediated by bacterial cell wall autolytic enzymes such as autolysins; it is possible that cephalexin interferes with an autolysin inhibitor. J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01D - Other beta-lactam antibacterials > J01DB - First-generation cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D002511 - Cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic CONFIDENCE standard compound; INTERNAL_ID 1046
EVOXINE
C18H21NO6 (347.13688060000004)
Methyl 4-(2-benzylbenzoyl)-2,5-dimethyl-1H-pyrrole-3-carboxylate
C22H21NO3 (347.15213560000007)
D002317 - Cardiovascular Agents > D014662 - Vasoconstrictor Agents > D002120 - Calcium Channel Agonists D000077264 - Calcium-Regulating Hormones and Agents D049990 - Membrane Transport Modulators
AS 1842856
C18H22FN3O3 (347.16451140000004)
Dide-O-methylsimmondsin
Dide-O-methylsimmondsin is found in coffee and coffee products. Dide-O-methylsimmondsin is a constituent of jojoba meal. Constituent of jojoba meal. Di-demethylsimmondsin is found in coffee and coffee products, fats and oils, and nuts.
1,2-Dimethoxy-13-methyl-[1,3]benzodioxolo[5,6-c]phenanthridine
C21H17NO4 (347.11575220000003)
1,2-Dimethoxy-13-methyl-[1,3]benzodioxolo[5,6-c]phenanthridine is found in fruits. 1,2-Dimethoxy-13-methyl-[1,3]benzodioxolo[5,6-c]phenanthridine is an alkaloid from root bark of Zanthoxylum simulans (Szechuan pepper). Alkaloid from root bark of Zanthoxylum simulans (Szechuan pepper). 1,2-Dimethoxy-13-methyl-[1,3]benzodioxolo[5,6-c]phenanthridine is found in herbs and spices and fruits.
Embramine
D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist Embramine is an ethanolamine H1-antihistamine.
5-Aminofluorescein
C20H13NO5 (347.07936880000005)
D004396 - Coloring Agents > D005456 - Fluorescent Dyes > D005452 - Fluoresceins
2-(3,6,9-Trihydroxy-4-amino-9H-xanthene-9-yl)benzoic acid gamma-lactone
C20H13NO5 (347.07936880000005)
Desmethylofloxacin
C17H18FN3O4 (347.12812800000006)
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D024841 - Fluoroquinolones
Eliprodil
D018377 - Neurotransmitter Agents > D018683 - Excitatory Amino Acid Agents > D018691 - Excitatory Amino Acid Antagonists D002491 - Central Nervous System Agents > D018696 - Neuroprotective Agents C26170 - Protective Agent > C1509 - Neuroprotective Agent D020011 - Protective Agents Eliprodil(SL-820715) is a non-competitive NR2B-NMDA receptor antagonist(IC50=1 uM), less potent for NR2A- and NR2C-containing receptors(IC50> 100 uM). IC50 value: Target: NR2B-NMDA antagonist Human N-type Ca2+ channel currents were inhibited by ifenprodil and eliprodil with IC50 values of 50 microM and 10 microM respectively whereas P-type Ca2+ channel currents were inhibited reversibly by ifenprodil and eliprodil with approximate IC50 values of 60 microM and 9 microM respectively. eliprodil (1 microm) produced a moderate reverse rate-dependent prolongation of the action potential duration (7.4+/-1.5, 8.9+/-2.1 and 9.9+/-1.8\% at cycle lengths of 300, 1000 and 5000 ms, respectively; n=9).
5-Amino-1-[(2R,3R,4S,5R)-5-[(benzylamino)methyl]-3,4-dihydroxyoxolan-2-yl]imidazole-4-carboxamide
C16H21N5O4 (347.15934660000005)
3-(4-((3-Phenoxybenzyl)amino)phenyl)propanoic acid
C22H21NO3 (347.15213560000007)
GW9508 is a potent and selective G protein-coupled receptors FFA1 (GPR40) and GPR120 agonist with pEC50s of 7.32 and 5.46, respectively. GW9508 shows ~100-fold selectivity for GPR40 over GPR120. GW9508 is inactive against other GPCRs, kinases, proteases, integrins and PPARs. GW9508 is a glucose-sensitive insulin secretagogue and an ATP-sensitive potassium (KATP) channels opener. Anti-inflammatory and anti-atherosclerotic activities[1][2][3][4].
Nafamostat
D007155 - Immunologic Factors > D007166 - Immunosuppressive Agents > D051056 - Complement Inactivating Agents COVID info from Guide to PHARMACOLOGY, clinicaltrial, clinicaltrials, clinical trial, clinical trials D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors > D015842 - Serine Proteinase Inhibitors C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D006401 - Hematologic Agents > D000925 - Anticoagulants C471 - Enzyme Inhibitor > C783 - Protease Inhibitor D000893 - Anti-Inflammatory Agents D018501 - Antirheumatic Agents Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
Naproxcinod
C18H21NO6 (347.13688060000004)
Nizatidine sulfoxide
C12H21N5O3S2 (347.10857560000005)
(4R)-4-Hydroxy-4-[6-[(5R)-5-(methoxymethyl)-2-oxo-1,3-oxazolidin-3-yl]-1,3-benzothiazol-2-yl]butanenitrile
C16H17N3O4S (347.09397220000005)
Leonurine HCl
Leonurine hydrochloride is an alkaloid isolated from Leonurus artemisia, with anti-oxidative and anti-inflammatory. Leonurine hydrochloride is an alkaloid isolated from Leonurus artemisia, with anti-oxidative and anti-inflammatory.
10,20-Dehydro[12,13-dehydroprolyl]-2-(1,1-dimethylallyltryptophyl)diketopiperazine
2-carboxymethyl-5-hydroxy-7-phenyl-2H-benzo[de]isoquinoline-1,6-dione
C20H13NO5 (347.07936880000005)
Clanobutin
C18H18ClNO4 (347.09242980000005)
C78276 - Agent Affecting Digestive System or Metabolism > C66913 - Cholagogues or Choleretic Agents
GW9508
C22H21NO3 (347.15213560000007)
GW9508 is a potent and selective G protein-coupled receptors FFA1 (GPR40) and GPR120 agonist with pEC50s of 7.32 and 5.46, respectively. GW9508 shows ~100-fold selectivity for GPR40 over GPR120. GW9508 is inactive against other GPCRs, kinases, proteases, integrins and PPARs. GW9508 is a glucose-sensitive insulin secretagogue and an ATP-sensitive potassium (KATP) channels opener. Anti-inflammatory and anti-atherosclerotic activities[1][2][3][4].
(+)-4-(6-methoxy-9-methyl-8-oxo-8,9-dihydro-[1,3]dioxolo[4,5-h]quinolin-7-yl)-2-methyl-butyric acid methyl ester|Pteleolin|Pteleoline
C18H21NO6 (347.13688060000004)
delta-(L-alpha-aminoadipoyl)-L-serine-D-valine|delta-(L-alpha-aminoadipyl)-L-seryl-D-valine|L,L,D-alpha-aminodipoyl-serinyl-valine
4-hydroxy-9-carboxynonenoic lactone mercapturic acid
C14H21NO7S (347.10386760000006)
(2S)-1-[(6,7-dimethoxyfuro[2,3-b]quinolin-4-yl)oxy]-3-methylbutane-2,3-diol
C18H21NO6 (347.13688060000004)
1,6-Dioxo-5-hydroxy-7-phenyl-1,2-dihydro-6H-benzo[de]isoquinoline-2-acetic acid
C20H13NO5 (347.07936880000005)
Me glycoside,Me ester,N,1,2-tri-Ac-alpha-D-Pyranose-4-Amino-4-deoxyglucuronic acid
(-)-circumdatin H|(5bS)-2-methoxy-5b,6,7,8-tetrahydro-10H,16H-pyrrolo[2,1-c]quinazolino[3,2-a]benzodiazepine-10,16-dione|(S)-(-)-circumdatin H|(S)-2-methoxy-5b,6,7,8-tetrahydrobenzo[6,7]pyrrolo[2,1:3,4][1,4]diazepino[2,1-b]quinazoline-10,16-dione|circumdatin H
C20H17N3O3 (347.12698520000004)
Leonurine HCl
Leonurine hydrochloride is an alkaloid isolated from Leonurus artemisia, with anti-oxidative and anti-inflammatory. Leonurine hydrochloride is an alkaloid isolated from Leonurus artemisia, with anti-oxidative and anti-inflammatory.
Cefalexin
C16H17N3O4S (347.09397220000005)
CONFIDENCE standard compound; EAWAG_UCHEM_ID 3014
Kinetin riboside
D006133 - Growth Substances > D010937 - Plant Growth Regulators > D003583 - Cytokinins relative retention time with respect to 9-anthracene Carboxylic Acid is 0.645 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.646 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.642 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.644 Kinetin riboside, a cytokinin analog, can induce apoptosis in cancer cells. It inhibits the proliferation of HCT-15 cells with an IC50 of 2.5 μM.
Cephalexin
C16H17N3O4S (347.09397220000005)
A semisynthetic first-generation cephalosporin antibiotic having methyl and beta-(2R)-2-amino-2-phenylacetamido groups at the 3- and 7- of the cephem skeleton, respectively. It is effective against both Gram-negative and Gram-positive organisms, and is used for treatment of infections of the skin, respiratory tract and urinary tract. J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01D - Other beta-lactam antibacterials > J01DB - First-generation cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D002511 - Cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic
Ala Gly Asn Ser
Ala Gly Ser Asn
Ala Asn Gly Ser
Ala Asn Ser Gly
Ala Ser Gly Asn
Ala Ser Asn Gly
Gly Ala Asn Ser
Gly Ala Ser Asn
Gly Gly Asn Thr
Gly Gly Gln Ser
Gly Gly Ser Gln
Gly Gly Thr Asn
Gly Asn Ala Ser
Gly Asn Gly Thr
Gly Asn Ser Ala
Gly Asn Thr Gly
Gly Gln Gly Ser
Gly Gln Ser Gly
Gly Ser Ala Asn
Gly Ser Gly Gln
Gly Ser Asn Ala
Gly Ser Gln Gly
Gly Thr Gly Asn
Gly Thr Asn Gly
Asn Ala Gly Ser
Asn Ala Ser Gly
Asn Gly Ala Ser
Asn Gly Gly Thr
Asn Gly Ser Ala
Asn Gly Thr Gly
Asn Ser Ala Gly
Asn Ser Gly Ala
Asn Thr Gly Gly
Gln Gly Gly Ser
Gln Gly Ser Gly
Gln Ser Gly Gly
Ser Ala Gly Asn
Ser Ala Asn Gly
Ser Gly Ala Asn
Ser Gly Gly Gln
Ser Gly Asn Ala
Ser Gly Gln Gly
Ser Asn Ala Gly
Ser Asn Gly Ala
Ser Gln Gly Gly
Thr Gly Gly Asn
Thr Gly Asn Gly
Thr Asn Gly Gly
GW 9508
C22H21NO3 (347.15213560000007)
GW9508 is a potent and selective G protein-coupled receptors FFA1 (GPR40) and GPR120 agonist with pEC50s of 7.32 and 5.46, respectively. GW9508 shows ~100-fold selectivity for GPR40 over GPR120. GW9508 is inactive against other GPCRs, kinases, proteases, integrins and PPARs. GW9508 is a glucose-sensitive insulin secretagogue and an ATP-sensitive potassium (KATP) channels opener. Anti-inflammatory and anti-atherosclerotic activities[1][2][3][4].
1,2-Dimethoxy-13-methyl-[1,3]benzodioxolo[5,6-c]phenanthridine
C21H17NO4 (347.11575220000003)
Pyrido[2,3-b][1,6]naphthyridine, 7-[2-(acetyloxy)benzoyl]-6,7,8,9-tetrahydro- (9CI)
C20H17N3O3 (347.12698520000004)
3-[BENZYL-(TOLUENE-4-SULFONYL)-AMINO]-2-METHYL-PROPIONIC ACID
1-naphthyl-n-acetyl-beta-d-glucosaminide
C18H21NO6 (347.13688060000004)
5-Pyrimidinecarbonitrile, 4-amino-2-(2,5-dihydroxyphenyl)-6-(3-piperidinyl)-, (HCl salt)
[5-(4-Methylphenyl)-1,2-oxazol-4-yl](4-phenyl-1-piperazinyl)metha none
Thiazolidine, 3-[(2,4-dimethylphenyl)sulfonyl]-2-(4-methylphenyl)- (9CI)
Thiazolidine, 3-[(4-ethylphenyl)sulfonyl]-2-(4-methylphenyl)- (9CI)
4-(Benzoylamino)-2,5-diethoxybenzenediazonium chloride
C17H18ClN3O3 (347.10366280000005)
diethyl 2-(trifluoromethoxy)phenylamino-n-methylenemalonate
C15H16F3NO5 (347.09805220000004)
Boc-(R)-3-Amino-4-(3-trifluoromethylphenyl)-butyric acid
C16H20F3NO4 (347.1344356000001)
Boc-(S)-3-Amino-4-(4-trifluoromethyl-phenyl)-butyric acid
C16H20F3NO4 (347.1344356000001)
5-(N-(4-butylphenyl)sulfamoyl)-2-Methylbenzoic acid
Urea, N-cyclopropyl-N-[(1,2-dihydro-6-methyl-2-oxo-3-quinolinyl)methyl]-N-phenyl- (9CI)
(E)-Methyl 3-(2-((tert-butyldimethylsilyloxy)methyl)furo[3,2-b]pyridin-6-yl)acrylate
Boc-(R)-3-amino-4-(2-trifluoromethylphenyl)-butyric acid
C16H20F3NO4 (347.1344356000001)
3-(3,4-Dimethoxy-benzoylamino)-3-(4-fluoro-phenyl)-propionic acid
C18H18FNO5 (347.11689500000006)
Adiphenine Hydrochloride
C20H26ClNO2 (347.16519660000006)
C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent Adiphenine hydrochloride is a non-competitive inhibitor of nicotinic acetylcholine receptor (nAChR), with an IC50s of 1.9, 1.8, 3.7, and 6.3 μM for α1, α3β4, α4β2, and α4β4, respectively. Adiphenine hydrochloride has anticonvulsant effects[1][2][3].
6-tert-Butyl-4-methyl-2-[(4-chloro-2-nitrophenyl)azo]phenol
C17H18ClN3O3 (347.10366280000005)
Bicyclo[2.2.1]heptan-2-amine,N-[(4-chlorophenyl)phenylmethyl]-, hydrochloride (1:1)
1-ETHYNYL-4-((4-((4-NITROPHENYL)ETHYNYL)PHENYL)ETHYNYL)BENZENE
ETHYL 2-(3-FORMYL-4-ISOBUTOXYPHENYL)-4-METHYLTHIAZOLE-5-CARBOXYLATE
2H-Pyrrol-2-one, 4-acetyl-1-(3-chloro-4-methylphenyl)-5-cyclohexyl-1,5-dihydro-3-hydroxy-
C19H22ClNO3 (347.1288132000001)
6-Chloro-2,3,4,5-tetrahydro-7,8-dimethoxy-1-(4-methoxyphenyl)-1H-3-benzazepine
C19H22ClNO3 (347.1288132000001)
Boc-(R)-3-amino-4-(4-trifluoromethylphenyl)-butyric acid
C16H20F3NO4 (347.1344356000001)
Boc-(S)-3-Amino-4-(2-trifluoromethylphenyl)-butyric acid
C16H20F3NO4 (347.1344356000001)
Boc-(S)-3-Amino-4-(3-trifluoromethyl-phenyl)-butyric acid
C16H20F3NO4 (347.1344356000001)
2-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)-1-TOSYL-1H-PYRROLE
C17H22BNO4S (347.13625220000006)
Methanone, [4-(5-chloro-2-methylphenyl)-1-piperazinyl](3-ethyl-5-methyl-4-isoxazolyl)
C18H22ClN3O2 (347.14004620000003)
Methanone, [4-(3-chlorophenyl)-1-piperazinyl][3-methyl-5-(1-methylethyl)-4-isoxazolyl]
C18H22ClN3O2 (347.14004620000003)
6-AMINO-1-[3-(CYCLOPENTYLOXY)-4-METHOXYBENZYL]-2-THIOXO-2,3-DIHYDROPYRIMIDIN-4(1H)-ONE
C17H21N3O3S (347.13035560000003)
methyl 2,3-dihydro-2-(3-hydroxy-2-quinolyl)-1,3-dioxo-1H-indene-5-carboxylate
C20H13NO5 (347.07936880000005)
(R)-(+)-N,N-DIMETHYL-1-(1-NAPHTHYL)ETHYLAMINE
C22H21NO3 (347.15213560000007)
Sulbactam pivoxil
C14H21NO7S (347.10386760000006)
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D010406 - Penicillins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C2140 - Adjuvant > C183118 - Beta-lactamase Inhibitor
PFI-1
C16H17N3O4S (347.09397220000005)
4-[[(4-tert-butylphenyl)sulfonylamino]methyl]benzoic acid
1-benzyl-4-(2-methoxy-phenyl)-pyrrolidine-3-carboxylic acid hydrochloride
C19H22ClNO3 (347.1288132000001)
trans-1-Benzyl-4-(4-methoxyphenyl)pyrrolidine-3-carboxylic acid
C19H22ClNO3 (347.1288132000001)
6-[5-({[2-(methylsulphonyl)ethyl]amino}methyl)furan-2-yl]quinazolin-4-ol
C16H17N3O4S (347.09397220000005)
(2R,3S,4S,5R,6R)-2-(Acetoxymethyl)-6-aminotetrahydro-2H-pyran-3,4,5-triyl triacetate
ethyl 2-piperazine-4-(4-methoxy)phenyl thiazole-5-carboxylate
C17H21N3O3S (347.13035560000003)
(2R,4S)-ethyl 5-([1,1-biphenyl]-4-yl)-4-amino-2-methylpentanoate hydrochloride
C20H26ClNO2 (347.16519660000006)
7-(PHENYLACETAMIDO)-4-(TRIFLUOROMETHYL)COUMARIN
C18H12F3NO3 (347.07692380000003)
(3R)-3-Piperidinecarboxylic acid, 3-(phenylmethyl)-, 1,2,2-trimethylhydrazide, hydrochloride (1:2)
N-[(2S)-3-Amino-2-hydroxypropyl]-N-[3-fluoro-4-(4-morpholinyl)phenyl]acetamide hydrochloride (1:1)
C15H23ClFN3O3 (347.14118900000005)
Benzyl 2-(methylsulfonyl)-7,8-dihydropyrido[4,3-d]pyrimidine-6(5H)-carboxylate
C16H17N3O4S (347.09397220000005)
DIETHYL 1,4-DIHYDRO-2,6-DIMETHYL-4-(4-F&
C19H22FNO4 (347.15327840000003)
3-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)-1-TOSYL-1H-PYRROLE
C17H22BNO4S (347.13625220000006)
2-(1,4-Diazepan-1-yl)-1,3-benzothiazoletrifluoroacetic acid salt
C14H16F3N3O2S (347.09152720000003)
nalorphine hydrochloride ciii (250 mg)
C19H22ClNO3 (347.1288132000001)
6-nitro-2-[(4-phenylpiperidin-1-yl)methyl]quinoline
naproxcinod
C18H21NO6 (347.13688060000004)
M - Musculo-skeletal system > M01 - Antiinflammatory and antirheumatic products > M01A - Antiinflammatory and antirheumatic products, non-steroids > M01AE - Propionic acid derivatives C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D002317 - Cardiovascular Agents > D020030 - Nitric Oxide Donors C471 - Enzyme Inhibitor > C1323 - Cyclooxygenase Inhibitor
L-779450
C20H14ClN3O (347.08253440000004)
L-779450 is a potent and selective B-Raf kinase inhibitor with a Kd of 2.4 nM.
Circumdatin H
C20H17N3O3 (347.12698520000004)
An organic heteropentacyclic compound that is 5b,7,8,16-tetrahydro-6H,10H-pyrrolo[2,1-c]quinazolino[3,2-a][1,4]benzodiazepine substituted by a methoxy group at position 2 and oxo groups at positions 10 and 16 (the 5bS stereoisomer). An alkaloid isolated from the culture broth of Aspergillus ochraceus, it exhibits potent inhibitory activity towards mitochondrial NADH oxidase.
4-[[2-[(6-methyl-4-oxo-1H-pyrimidin-2-yl)thio]-1-oxoethyl]amino]benzoic acid ethyl ester
C16H17N3O4S (347.09397220000005)
2-[3-(3,4-Dimethoxyphenyl)pyrazolo[1,5-a]pyrimidin-5-yl]benzenol
C20H17N3O3 (347.12698520000004)
N-[1-(4-methyl-6-oxo-1-pyrimidinyl)-2-oxo-2-phenylethyl]benzamide
C20H17N3O3 (347.12698520000004)
N-[2-(3-oxo-4H-quinoxalin-2-yl)phenyl]-2-thiophenecarboxamide
C19H13N3O2S (347.07284380000004)
N2-(2-methoxyphenyl)-6-(3-methyl-2-benzofuranyl)-1,3,5-triazine-2,4-diamine
1-phenyl-N-[4-(pyridin-2-yl)-1,3-thiazol-2-yl]-1H-imidazole-5-carboxamide
C18H13N5OS (347.08407680000005)
N-cyclopropyl-2,6-dimethyl-4-(5-methyl-1,3,4-oxadiazol-2-yl)biphenyl-3-carboxamide
N-(Cyclopropylmethyl)-2-Methyl-5-(5-Methyl-1,3,4-Oxadiazol-2-Yl)biphenyl-4-Carboxamide
(3S,5R,7R,8S,9S,10R)-7-(hydroxymethyl)-3-(2-naphthyl)-1,6-dioxa-2-azaspiro[4.5]decane-8,9,10-triol
C18H21NO6 (347.13688060000004)
delta-(L-alpha-Aminoadipoyl)-L-cysteinyl-D-vinylglycine
Nafamostat
D007155 - Immunologic Factors > D007166 - Immunosuppressive Agents > D051056 - Complement Inactivating Agents COVID info from Guide to PHARMACOLOGY, clinicaltrial, clinicaltrials, clinical trial, clinical trials D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors > D015842 - Serine Proteinase Inhibitors C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D006401 - Hematologic Agents > D000925 - Anticoagulants C471 - Enzyme Inhibitor > C783 - Protease Inhibitor D000893 - Anti-Inflammatory Agents D018501 - Antirheumatic Agents Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
Embramine
D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist
BSPBio_000729
C18H21NO6 (347.13688060000004)
(2R,3R,4S,5R)-2-[6-(furan-2-ylmethylamino)purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol
D006133 - Growth Substances > D010937 - Plant Growth Regulators > D003583 - Cytokinins
(4R)-4-Hydroxy-4-[6-[(5R)-5-(methoxymethyl)-2-oxo-1,3-oxazolidin-3-yl]-1,3-benzothiazol-2-yl]butanenitrile
C16H17N3O4S (347.09397220000005)
(1E,2Z)-3-hydroxy-5,9,17-trioxo-4,5:9,10-disecoandrosta-1(10),2-dien-4-oate
(1R,2R,5R,8R,9S,10R,11R,12R,13S)-12,13-dihydroxy-11-methyl-6-methylidene-16-oxo-15-oxapentacyclo[9.3.2.15,8.01,10.02,8]heptadecane-9-carboxylate
(1R,2R,5S,8S,9S,10R,11R,12S)-5,12-dihydroxy-11-methyl-6-methylidene-16-oxo-15-oxapentacyclo[9.3.2.15,8.01,10.02,8]heptadecane-9-carboxylate
(1R,2R,5S,8S,9S,10R,11S,13R)-5,13-dihydroxy-11-methyl-6-methylidene-16-oxo-15-oxapentacyclo[9.3.2.15,8.01,10.02,8]heptadecane-9-carboxylate
L-methionyl-3-{[(2E)-4-methoxy-4-oxobut-2-enoyl]amino}alanine
L-Met-3-[[(E)-4-Methoxy-4-oxo-2-butenoyl]amino]-L-Ala-OH
1,1-Ethenediamine, N-[2-[[[2-[(dimethylamino)methyl]-4-thiazolyl]methyl]sulfinyl]ethyl]-N-methyl-2-nitro-
C12H21N5O3S2 (347.10857560000005)
Leu-Thr-Asp
A tripeptide composed of L-leucine, L-threonine and L-aspartic acid joined in sequence by peptide linkages.
1-(3,4-Dimethoxyphenyl)-3-(2-methoxy-5-nitrophenyl)urea
4-chloro-N-(4-imidazo[1,2-a]pyridin-2-ylphenyl)benzamide
C20H14ClN3O (347.08253440000004)
6-(1,3-benzodioxol-5-yl)-N-(cyclopentylmethyl)-4-quinazolinamine
Acetic acid [2-[acetyl-(4-methylphenyl)sulfonylamino]phenyl] ester
C17H17NO5S (347.08273920000005)
2-hydroxy-2,2-bis(4-methylphenyl)-N-(2-pyridinyl)acetohydrazide
N-[[(6-methyl-2-pyridinyl)amino]-sulfanylidenemethyl]-4-phenylbenzamide
[2-(Methylthio)phenyl]-[1-[oxo(4-thiadiazolyl)methyl]-3-piperidinyl]methanone
(1-Methyl-3-indolyl)-diphenyl-sulfanylidenephosphorane
C21H18NPS (347.08975180000004)
1-[4-(3,5-Dimethoxyphenyl)-2-thiazolyl]-4-piperidinecarboxamide
C17H21N3O3S (347.13035560000003)
Glu-Ile-Ser
A tripeptide composed of L-glutamic acid, L-isoleucine and L-serine joined by peptide linkages.
1-(2-Chloro-4-nitrophenyl)-4-(2-methoxyphenyl)piperazine
C17H18ClN3O3 (347.10366280000005)
1-(3-Methoxyphenyl)-3-[5-(2-methyl-1-piperidinyl)-1,3,4-thiadiazol-2-yl]urea
C16H21N5O2S (347.14158860000003)
N-[(R)-[(1R,2R)-2-butylcyclopropyl]-(4-chlorophenyl)methyl]-2-thiophenecarboxamide
C19H22ClNOS (347.11105520000007)
1-[2-(Dimethylamino)ethyl]-3-(2,4-dimethylphenyl)-1-(thiophen-2-ylmethyl)thiourea
6-(3-methoxyphenyl)-N-(thiophen-2-ylmethyl)-4-quinazolinamine
3-[[[3-(4-Methoxyphenyl)phenyl]-oxomethyl]amino]benzoic acid
C21H17NO4 (347.11575220000003)
6-Amino-5-cyano-2-phenyl-4-pyridin-4-yl-4H-pyran-3-carboxylic acid ethyl ester
C20H17N3O3 (347.12698520000004)
1-[[(4-Ethyl-5-methyl-3-thiophenyl)-oxomethyl]amino]-3-(2-phenylethyl)thiourea
N-[4-(4-acetyl-1-piperazinyl)-3-chlorophenyl]-2-furancarboxamide
C17H18ClN3O3 (347.10366280000005)
N-(2,5-dimethoxyphenyl)-4-(2,4-dimethyl-5-thiazolyl)-2-thiazolamine
6-(2-Furanyl)-3-methyl-1-phenyl-4-pyrazolo[3,4-b]pyridinecarboxylic acid ethyl ester
C20H17N3O3 (347.12698520000004)
6-Chloro-4-[[(2-fluorophenyl)methyl-methylamino]methyl]-7-hydroxy-1-benzopyran-2-one
C18H15ClFNO3 (347.07244420000006)
[2-(Methylamino)-2-oxoethyl] 1-(4-fluorophenyl)-3-methylthieno[2,3-c]pyrazole-5-carboxylate
3-(2,4-dioxo-1H-thieno[3,2-d]pyrimidin-3-yl)-N-(3-fluoro-4-methylphenyl)propanamide
5-[[3-Methyl-1-(4-methylphenyl)-5-oxo-4-pyrazolylidene]methylamino]-1,3-dihydrobenzimidazol-2-one
N-[(4-tert-butylcyclohexylidene)amino]-3-chloro-5-(trifluoromethyl)-2-pyridinamine
N-[1-(1,3-dioxo-1,3,3a,4,7,7a-hexahydro-2H-4,7-methanoisoindol-2-yl)ethyl]-N-(5-methyl-1,3,4-thiadiazol-2-yl)urea
3-(1,3-Dihydrobenzimidazol-2-ylidene)-1-pentylquinoline-2,4-dione
3-(6-Methylpyridin-2-yl)-2-(4-pyridin-3-ylphenyl)-1,3-thiazolidin-4-one
Met-FMDP
A dipeptide composed of 3-{[(2E)-4-methoxy-4-oxobut-2-enoyl]amino}alanine and L-methionine joined by peptide linkages.
7-(diethylamino)-4-(1-methyl-1H-benzimidazol-2-yl)-2H-chromen-2-one
N-[3-(dimethylamino)propyl]-N-(4-fluoro-1,3-benzothiazol-2-yl)-2-furancarboxamide
C17H18FN3O2S (347.11037000000005)
2-[2-Fluoro-4-chloro-5-[(S)-1-methyl-2-propynyloxy]phenyl]-4,5,6,7-tetrahydro-2H-isoindole-1,3-dione
C18H15ClFNO3 (347.07244420000006)
2-[2-Fluoro-4-chloro-5-[(R)-1-methyl-2-propynyloxy]phenyl]-4,5,6,7-tetrahydro-2H-isoindole-1,3-dione
C18H15ClFNO3 (347.07244420000006)
5-dioxooctahydro-1H-inden-4-yl]-6-oxoocta-2,4-dienoate
(2R,3S,4S)-1-[cyclobutyl(oxo)methyl]-4-(hydroxymethyl)-3-[4-(3-pyridinyl)phenyl]-2-azetidinecarbonitrile
1-[(3aS,4S,9bS)-4-(hydroxymethyl)-8-[2-(3-pyridinyl)ethynyl]-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-1-yl]ethanone
1-[(3aR,4R,9bR)-4-(hydroxymethyl)-8-[2-(3-pyridinyl)ethynyl]-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-1-yl]ethanone
1-[(3aR,4S,9bR)-4-(hydroxymethyl)-8-[2-(3-pyridinyl)ethynyl]-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-1-yl]ethanone
3-[(2,5-Dimethoxyphenyl)iminomethyl]-1,5-dioxaspiro[5.5]undecane-2,4-dione
C18H21NO6 (347.13688060000004)
5-[(E)-[[7-(hydroxyamino)-7-oxoheptanoyl]hydrazinylidene]methyl]furan-2-sulfonic acid
2-[1-(1,3-dimethyl-2,4,6-trioxotetrahydropyrimidin-5(2H)-ylidene)ethyl]-N-phenylhydrazinecarbothioamide
Butyl N-trifluoroacetyl 2-N-methylaminoethyl phosphonate
Dibutyl 1-(N-trifuoroacetylamino)propylphosphonate
2 inverted exclamation marka-Deoxy-N-(2-furanylmethyl)guanosine
dicyanide
C20H13NO5 (347.07936880000005)
Hydroxysanguinarine is a benzophenanthridine alkaloid. Hydroxysanguinarine is a natural product found in Fumaria indica, Fumaria parviflora, and other organisms with data available.
Eliprodil
D018377 - Neurotransmitter Agents > D018683 - Excitatory Amino Acid Agents > D018691 - Excitatory Amino Acid Antagonists D002491 - Central Nervous System Agents > D018696 - Neuroprotective Agents C26170 - Protective Agent > C1509 - Neuroprotective Agent D020011 - Protective Agents Eliprodil(SL-820715) is a non-competitive NR2B-NMDA receptor antagonist(IC50=1 uM), less potent for NR2A- and NR2C-containing receptors(IC50> 100 uM). IC50 value: Target: NR2B-NMDA antagonist Human N-type Ca2+ channel currents were inhibited by ifenprodil and eliprodil with IC50 values of 50 microM and 10 microM respectively whereas P-type Ca2+ channel currents were inhibited reversibly by ifenprodil and eliprodil with approximate IC50 values of 60 microM and 9 microM respectively. eliprodil (1 microm) produced a moderate reverse rate-dependent prolongation of the action potential duration (7.4+/-1.5, 8.9+/-2.1 and 9.9+/-1.8\% at cycle lengths of 300, 1000 and 5000 ms, respectively; n=9).
5-Aminofluorescein
C20H13NO5 (347.07936880000005)
D004396 - Coloring Agents > D005456 - Fluorescent Dyes > D005452 - Fluoresceins
FPL64176
C22H21NO3 (347.15213560000007)
D002317 - Cardiovascular Agents > D014662 - Vasoconstrictor Agents > D002120 - Calcium Channel Agonists D000077264 - Calcium-Regulating Hormones and Agents D049990 - Membrane Transport Modulators
(2R)-1-[(4,8-dimethoxy-7-furo[2,3-b]quinolinyl)oxy]-3-methylbutane-2,3-diol
C18H21NO6 (347.13688060000004)
1-naphthyl N-acetyl-beta-D-glucosaminide
C18H21NO6 (347.13688060000004)
An N-acetyl-beta-D-glucosaminide in which the anomeric hydroxy hydrogen is replaced by a 1-naphthyl group.
5-carboxymethylaminomethyl-2-thiouridine
A thiouridine that is 2-thiouridine bearing an additional carboxymethylaminomethyl substituent at position 5 on the thiouracil ring.
GP531
C16H21N5O4 (347.15934660000005)
GP531 is a potent, second-generation adenosine regulating agent, is pharmacologically silent under basal conditions but increases localized endogenous adenosine during ischemia.
2-hydroxy-7-methoxy-10,13-dimethyl-9,18-dioxo-10-azapentacyclo[9.7.1.0²,¹⁰.0³,⁸.0¹⁵,¹⁹]nonadeca-1(19),3(8),4,6,12,14,16-heptaen-10-ium-11-ide
C21H17NO4 (347.11575220000003)
7-hydroxy-19-[(1s)-1-hydroxyethyl]-3,13,17-triazapentacyclo[11.8.0.0²,¹⁰.0⁴,⁹.0¹⁵,²⁰]henicosa-1(21),2(10),4,6,8,15,17,19-octaen-14-one
C20H17N3O3 (347.12698520000004)
methyl (2s)-2-hydroxy-3,3-dimethoxy-4-methyl-1,9-dioxocyclopenta[b]quinoline-2-carboxylate
(1s,13s,15r,16s,18r,19r)-9,15-dimethoxy-5,7,17-trioxa-12-azahexacyclo[10.6.2.0¹,¹³.0²,¹⁰.0⁴,⁸.0¹⁶,¹⁸]icosa-2,4(8),9-trien-19-ol
C18H21NO6 (347.13688060000004)
(2r)-1-({4,7-dimethoxyfuro[2,3-b]quinolin-6-yl}oxy)-3-methylbutane-2,3-diol
C18H21NO6 (347.13688060000004)
methyl 2-hydroxy-3-{4-[5-hydroxy-4-(2-methylpropyl)-2-oxopyrrol-3-yl]phenoxy}propanoate
C18H21NO6 (347.13688060000004)
9,15-dimethoxy-5,7,17-trioxa-12-azahexacyclo[10.6.2.0¹,¹³.0²,¹⁰.0⁴,⁸.0¹⁶,¹⁸]icosa-2(10),3,8-trien-11-ol
C18H21NO6 (347.13688060000004)
(2s)-1-({7,8-dimethoxyfuro[2,3-b]quinolin-4-yl}oxy)-3-methylbutane-2,3-diol
C18H21NO6 (347.13688060000004)
(1s)-21-methyl-14-oxo-3,13,21-triazapentacyclo[11.8.0.0²,¹⁰.0⁴,⁹.0¹⁵,²⁰]henicosa-2(10),4,6,8,15,17,19-heptaene-12-carboxylic acid
C20H17N3O3 (347.12698520000004)
9,15-dimethoxy-5,7,17-trioxa-12-azahexacyclo[10.6.2.0¹,¹³.0²,¹⁰.0⁴,⁸.0¹⁶,¹⁸]icosa-2,4(8),9-trien-19-ol
C18H21NO6 (347.13688060000004)
15-hydroxy-9,16-dimethoxy-3-methyl-7,11-dioxa-3-azapentacyclo[8.8.0.0²,⁶.0⁶,⁸.0¹³,¹⁸]octadeca-13(18),14,16-trien-12-one
C18H21NO6 (347.13688060000004)
(1r,5's,6'r,7'ar)-5',6'-dihydroxy-5,6-dimethoxy-1'-methyl-3',5',6',7'a-tetrahydro-2'h-spiro[2-benzofuran-1,7'-indol]-3-one
C18H21NO6 (347.13688060000004)
1-hydroxy-3-{[2-(2-methylbut-3-en-2-yl)-1h-indol-3-yl]methylidene}-6h,7h-pyrrolo[1,2-a]pyrazin-4-one
(2s,3s,6r,12r)-3,12-dihydroxy-4-methoxy-16,18-dioxa-10-azapentacyclo[11.7.0.0²,⁶.0⁶,¹⁰.0¹⁵,¹⁹]icosa-1(20),4,13,15(19)-tetraen-10-ium-10-olate
C18H21NO6 (347.13688060000004)
1-({7,8-dimethoxyfuro[2,3-b]quinolin-4-yl}oxy)-3-methylbutane-2,3-diol
C18H21NO6 (347.13688060000004)
4-ethylidene-7-hydroxy-6,7-dimethyl-2,9-dioxa-14-azatricyclo[9.5.1.0¹⁴,¹⁷]heptadeca-11(17),12-diene-3,8,15-trione
C18H21NO6 (347.13688060000004)